Johnson & Johnson Earnings Expected Tuesday

Analysts forecast Q1 2026 results for the healthcare giant

Apr. 7, 2026 at 5:53am

Got story updates? Submit your updates here. ›

A cinematic close-up of heavy, polished banking machinery and mechanical components conveying a sense of institutional financial power and security without using literal currency or charts.Johnson & Johnson's Q1 2026 earnings report will offer a glimpse into the financial health and operational machinery of one of the world's largest healthcare conglomerates.New Brunswick Today

Johnson & Johnson (NYSE:JNJ) is expected to release its Q1 2026 earnings results before the market opens on Tuesday, April 14. Analysts predict the company will report earnings of $2.68 per share and revenue of $23.6038 billion for the quarter.

Why it matters

As one of the world's largest healthcare companies, Johnson & Johnson's quarterly earnings are closely watched by investors and analysts as an indicator of the broader pharmaceutical and medical device industries. The company's performance can impact stock prices and influence investment decisions.

The details

Johnson & Johnson will host a conference call to discuss the Q1 2026 results on Tuesday, April 14 at 8:30 AM ET. The company reported earnings of $2.46 per share and revenue of $24.28 billion in its most recent quarter. Analysts expect Johnson & Johnson to post full-year 2026 earnings of $11 per share.

  • Johnson & Johnson will release Q1 2026 earnings on Tuesday, April 14, 2026 before the market opens.
  • The company's earnings call is scheduled for 8:30 AM ET on April 14, 2026.

The players

Johnson & Johnson

A multinational healthcare company headquartered in New Brunswick, New Jersey that develops, manufactures and markets pharmaceutical, medical device, and consumer health products.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Johnson & Johnson's Q1 2026 earnings report and conference call for insights into the company's financial performance, product pipeline, and outlook for the rest of the year.

The takeaway

As a bellwether for the healthcare industry, Johnson & Johnson's quarterly results provide valuable data points on the state of the pharmaceutical, medical device, and consumer health markets. The company's performance is closely tied to broader economic and industry trends.